|
|
||||||||
The Annals of Thoracic Surgery, Vol 40, 374-379, Copyright © 1985 by The Society of Thoracic Surgeons
RM Bodenhamer, RG Johnson, JD Randolph, G Pohost, C Boucher, R Okada, E Lowenstein, FH Levine and WM Daggett
To determine if the myocardial protection afforded by a cold crystalloid
potassium cardioplegic solution could be improved by the addition of either
mannitol or albumin, a prospective clinical study was undertaken in which
58 patients undergoing elective aortocoronary bypass were randomized to one
of three groups. Each group featured a different cardioplegic solution. The
solutions were a standard potassium crystalloid solution, a solution
containing mannitol sufficient to raise the osmolality by 20 to 30 mOsm,
and a solution containing 5% albumin. Preoperative, intraoperative, and
postoperative evaluation included serial measurements of ejection fraction,
myocardial-specific isoenzyme, and hemodynamic indexes of performance.
Electrocardiographic evaluation for perioperative myocardial infarction and
the need for postoperative inotropic and mechanical support were also
included. No differences were found among the groups. Therefore, although
the use of mannitol or albumin has been shown to be beneficial in an
experimental setting, superiority of either additive could not be
demonstrated clinically.
ARTICLES
The effect of adding mannitol or albumin to a crystalloid cardioplegic solution: a prospective, randomized clinical study
This article has been cited by other articles:
![]() |
M. M. Wilkes and R. J. Navickis Patient Survival after Human Albumin Administration: A Meta-Analysis of Randomized, Controlled Trials Ann Intern Med, August 7, 2001; 135(3): 149 - 164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |